-
Professor YongHong Xiao’s Commentary on Cefiderocol Treatment of Gram-Negative Bacteremia in the GAMECHANGER Study | ESCMID Global 2024
Cefiderocol is a novel siderophore cephalosporin antibiotic with excellent stability against nearly all β-lactamases, including metalloenzymes. It has demonstrated good clinical efficacy against infections caused by carbapenem-resistant Gram-negative bacteria (CRO), garnering significant attention from experts in the field of infectious diseases. At the 34th European Congress of Clinical Microbiology and Infectious Diseases (ESCMID Global 2024),…
-
Unveiling Progress in Immunotherapy and Pathological Diagnosis for Urological Cancers: Insights from Dr. Félix Guerrero Ramos and Dr. Xuefeng Qiu at EAU Congress 2024
In a significant gathering at the European Association of Urology (EAU) Congress 2024, held in the vibrant city of Paris, two esteemed figures in the field of urology, Dr. Félix…
-
Professor ChunRong Ju’s Comments: Focus on Long-Term Infections in Solid Organ Transplant Recipients | ESCMID Global 2024
Infection remains a major challenge for recipients of solid organ transplants (SOT), leading to serious risks of mortality and transplant failure. Previous research has primarily focused on the characteristics and prevention of infections within the first year post-surgery, with limited data on long-term infections beyond one year post-surgery. At the recent 34th European Society of…
-
Optimizing Antibiotic Dosage in Obese and Underweight Patients: Insights from Professor Wenxiang Huang ‘s Presentation at ESCMID Global 2024
From April 27th to 30th, 2024, the 34th European Congress of Clinical Microbiology and Infectious Diseases (ESCMID Global 2024) took place in Barcelona, Spain, known as the “Pearl of the Iberian Peninsula.” ESCMID Global, formerly known as ECCMID, stands as one of the most influential international conferences in the field of infectious diseases. Often, clinical…
-
Dr. Raksha Kochi: Interpreting Gram Stain Results with ChatGPT | ESCMID Global 2024
Editor’s Note: Traditional microbiology laboratory methods such as Gram staining and antimicrobial susceptibility testing still rely on manual interpretation of results and report generation. The introduction of artificial intelligence (AI)…
-
Professor Tiejun Gong: Striving for Excellence, 2024 CSCO Guidelines on Malignant Hematology with a Focus on Leukemia | 2024 CSCO Guidelines Conference
The 2024 China Clinical Oncology Society (CSCO) Guidelines Conference was held in Jinan on April 26-27, 2024. As always, the conference updated and released multiple CSCO cancer treatment guidelines. Professor Tiejun Gong, Deputy Director of the Harbin Institute of Hematologic Oncology, gave an insightful interpretation of the leukemia section in the “2024 CSCO Guidelines on…
-
EBMT 2024 | Dr. Li Gao：The MRD status on day 7 and CD4 count at 1 month after CAR-T therapy are prognostic indicators in CAR-T treatments
From April 14 to 17, 2024, the 50th Annual Congress of the European Society for Blood and Marrow Transplantation (EBMT) was held with great ceremony in Glasgow, UK. The conference focused on the latest advancements in stem cell transplantation and cell therapy, advancing patients with hematological diseases towards better clinical prognoses. At this congress, Dr.…
-
2024 CUDA Yanqi Lake Conference | Professor Xuesong Li: Optimizing Prostate Cancer Management to Safeguard Men’s Lives
The “4th Chinese Medical Association Urology Surgeons Branch Yanqi Lake Conference (2024)” was successfully held in Beijing from April 13th to 14th. The conference not only focused on clinical practices in urology surgery but also discussed cutting-edge developments and important topics in the industry. At the conference, Professor Xuesong Li from Peking University First Hospital…
Connecting Medical Expertise through Media